Base de dados : MEDLINE
Pesquisa : F03.625.094 [Categoria DeCS]
Referências encontradas : 2511 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 252 ir para página                         

  1 / 2511 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27770673
[Au] Autor:Sari Gokten E; Saday Duman N; Soylu N; Uzun ME
[Ad] Endereço:Yuksek Ihtisas Training ve Research Hospital, Bursa, Child and Adolescent Psychiatry, Turkey. Electronic address: esgokten@hotmail.com.
[Ti] Título:Effects of attention-deficit/hyperactivity disorder on child abuse and neglect.
[So] Source:Child Abuse Negl;62:1-9, 2016 12.
[Is] ISSN:1873-7757
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:It is known that children with mental and developmental problems are at risk of abuse and neglect. Attention-deficit/hyperactivity disorder is one of the most frequent neurodevelopmental disorders in children and adolescents. The purpose of this study is to examine whether children diagnosed with ADHD are under more risk in terms of child abuse and neglect compared to controls. In this case-control study, 104 children, who applied to Child and Adolescent Psychiatry Unit of Bursa Yuksek Ihtisas Training and Research Hospital between January and June 2015, were diagnosed with ADHD, and had no other psychiatric comorbidity except for disruptive behavior disorders, and 104 healthy children were compared. Abuse Assessment Questionnaire was applied to children after approval of the families was received. It was determined that the children diagnosed with ADHD were exposed to more physical (96.2%) and emotional abuse (87.5%) in a statistically significant way compared to controls (46.2%; 34.6%), they were exposed to physical and emotional neglect (5.8%) at a lower rate compared to healthy children (24.0%), and there was no difference between them and healthy children in terms of witnessing family violence (56.7%; 47.1%) and being exposed to sexual abuse (5.8%; 1.9%). The children diagnosed with ADHD were exposed to physical and emotional abuse at a higher rate; further studies should emphasize the role of parents in this topic and how parental education and treatment programs change the results.
[Mh] Termos MeSH primário: Transtorno do Deficit de Atenção com Hiperatividade/epidemiologia
Transtorno do Deficit de Atenção com Hiperatividade/psicologia
Maus-Tratos Infantis/estatística & dados numéricos
[Mh] Termos MeSH secundário: Transtorno do Deficit de Atenção com Hiperatividade/diagnóstico
Transtornos de Deficit da Atenção e do Comportamento Disruptivo
Estudos de Casos e Controles
Criança
Maus-Tratos Infantis/diagnóstico
Maus-Tratos Infantis/psicologia
Abuso Sexual na Infância/diagnóstico
Abuso Sexual na Infância/psicologia
Abuso Sexual na Infância/estatística & dados numéricos
Comorbidade
Estudos Transversais
Violência Doméstica
Feminino
Seres Humanos
Masculino
Transtornos do Neurodesenvolvimento
Pais/psicologia
Fatores de Risco
Fatores Socioeconômicos
Estatística como Assunto
Inquéritos e Questionários
Turquia
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180216
[Lr] Data última revisão:
180216
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:161023
[St] Status:MEDLINE


  2 / 2511 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Registro de Ensaios Clínicos
Texto completo
[PMID]:29173736
[Au] Autor:Barterian JA; Arnold LE; Brown NV; Farmer CA; Williams C; Findling RL; Kolko DJ; Bukstein OG; Molina BSG; Townsend L; Aman MG
[Ad] Endereço:The Ohio State University-Wexner Medical Center, Columbus. Electronic address: Justin.Barterian@osumc.edu.
[Ti] Título:Clinical Implications From the Treatment of Severe Childhood Aggression (TOSCA) Study: A Re-Analysis and Integration of Findings.
[So] Source:J Am Acad Child Adolesc Psychiatry;56(12):1026-1033, 2017 Dec.
[Is] ISSN:1527-5418
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:OBJECTIVE: The Treatment of Severe Childhood Aggression (TOSCA) project examined augmentation of stimulant treatment and parent training (PT) with risperidone for severe physical aggression. This article summarizes the clinical implications; reanalyzes the data to examine the utility of 4 criteria for deciding to augment; and presents a treatment algorithm. METHOD: The newly analyzed 4 criteria for augmenting after 3 weeks of stimulant and PT treatment consisted of not meeting a Clinical Global Impressions-Improvement (CGI-I) score of 1 and a normal score (≤15) on the Nisonger Child Behavior Rating Form Disruptive-Total (D-Total); a CGI-I score of 1 or 2 plus 25% improvement in D-Total score; a D-Total score no higher than 15; and a CGI-Severity score of 3 (mild) or better. Effect sizes were calculated. Prior TOSCA publications were reviewed for clinically relevant findings. RESULTS: All 4 criteria resulted in medium or better effect sizes (d = 0.59-0.72) when comparing risperidone with placebo. Providing risperidone to children who did not reach a CGI-I score of 1 plus a D-Total score no higher than 15 resulted in the greatest benefit. In addition, a review of clinically relevant data suggests that stimulant plus PT shows further improvement after 3 weeks even without augmentation. CONCLUSION: For those children who did not attain a CGI-I score of 1 and a D-total score no higher than 15, adding risperidone maximized the number of children benefitting from treatment and the average amount of benefit. Unless clinical circumstances dictate otherwise, practitioners should delay an antipsychotic drug for at least 1 month after the optimal stimulant dose is achieved and PT has commenced. Clinical trial registration information-Treatment of Severe Childhood Aggression (The TOSCA Study); http://clinicaltrials.gov; NCT00796302.
[Mh] Termos MeSH primário: Agressão
Antipsicóticos/uso terapêutico
Transtornos de Deficit da Atenção e do Comportamento Disruptivo/terapia
Estimulantes do Sistema Nervoso Central/uso terapêutico
Pais/educação
Risperidona/uso terapêutico
[Mh] Termos MeSH secundário: Transtornos de Deficit da Atenção e do Comportamento Disruptivo/diagnóstico
Transtornos de Deficit da Atenção e do Comportamento Disruptivo/psicologia
Criança
Terapia Combinada
Esquema de Medicação
Quimioterapia Combinada
Feminino
Seguimentos
Seres Humanos
Masculino
Escalas de Graduação Psiquiátrica
Resultado do Tratamento
[Pt] Tipo de publicação:JOURNAL ARTICLE; RANDOMIZED CONTROLLED TRIAL
[Nm] Nome de substância:
0 (Antipsychotic Agents); 0 (Central Nervous System Stimulants); L6UH7ZF8HC (Risperidone)
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180207
[Lr] Data última revisão:
180207
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171128
[Cl] Clinical Trial:ClinicalTrial
[St] Status:MEDLINE


  3 / 2511 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28456023
[Au] Autor:Cerniglia L; Muratori P; Milone A; Paciello M; Ruglioni L; Cimino S; Levantini V; Tambelli R
[Ad] Endereço:International Telematic University Uninettuno, Psychology Faculty, Department of Psychology, Corso Vittorio Emanuele II, 39 - 00100, Rome, Italy. Electronic address: l.cerniglia@uninettunouniversity.net.
[Ti] Título:Paternal psychopathological risk and psychological functioning in children with eating disorders and Disruptive Behavior Disorder.
[So] Source:Psychiatry Res;254:60-66, 2017 Aug.
[Is] ISSN:1872-7123
[Cp] País de publicação:Ireland
[La] Idioma:eng
[Ab] Resumo:Several studies demonstrated that maternal psychopathological risk is related to child's maladjustment, but until recently research has relatively neglected fathers. Disruptive Behavior Disorder (DBD) and Eating disorders (ED) have a large prevalence during childhood but a few studies have focused on their association with paternal psychopathological risk. One-hundred and thirty-nine children and their fathers were recruited from pediatric hospitals and outpatient clinics and paired with a healthy control group (CG). Fathers were administered the SCL-90/R and the CBCL 6-18 to assess: 1) psychopathological risk of fathers of children with DBD, ED and CG; 2) significant differences between ED and DBD fathers' psychopathological profiles; and 3) associations between specific fathers' psychopathological symptoms and children's emotional-behavioral problems. Fathers of children with ED showed a higher psychopathological risk than fathers of DBD offspring. Children with DBD showed higher externalizing symptoms. Paternal hostility was associated with internalizing problems in children with DBD. Paternal hostility showed a non-significant but clinically interesting association with internalizing problems in DBD children; interpersonal sensitivity was associated with internalizing problems in ED children. This study can constitute a contribution to a better understanding of the clinical characteristics of fathers of children with DBD and ED.
[Mh] Termos MeSH primário: Transtornos de Deficit da Atenção e do Comportamento Disruptivo/diagnóstico
Transtornos de Deficit da Atenção e do Comportamento Disruptivo/psicologia
Relações Pai-Filho
Pai/psicologia
Transtornos da Alimentação e da Ingestão de Alimentos/diagnóstico
Transtornos da Alimentação e da Ingestão de Alimentos/psicologia
[Mh] Termos MeSH secundário: Transtornos de Deficit da Atenção e do Comportamento Disruptivo/epidemiologia
Criança
Pré-Escolar
Emoções
Transtornos da Alimentação e da Ingestão de Alimentos/epidemiologia
Feminino
Seres Humanos
Masculino
Psicopatologia
Autorrelato
Inquéritos e Questionários
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1801
[Cu] Atualização por classe:180131
[Lr] Data última revisão:
180131
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170430
[St] Status:MEDLINE


  4 / 2511 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27776561
[Au] Autor:Mina TH; Lahti M; Drake AJ; Räikkönen K; Minnis H; Denison FC; Norman JE; Reynolds RM
[Ad] Endereço:University BHF Centre for Cardiovascular Sciences, Queen's Medical Research Institute, University of Edinburgh,Edinburgh, Scotland,UK.
[Ti] Título:Prenatal exposure to very severe maternal obesity is associated with adverse neuropsychiatric outcomes in children.
[So] Source:Psychol Med;47(2):353-362, 2017 Jan.
[Is] ISSN:1469-8978
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Prenatal maternal obesity has been linked to adverse childhood neuropsychiatric outcomes, including increased symptoms of attention deficit hyperactivity disorder (ADHD), internalizing and externalizing problems, affective disorders and neurodevelopmental problems but few studies have studied neuropsychiatric outcomes among offspring born to very severely obese women or assessed potential familial confounding by maternal psychological distress. METHOD: We evaluated neuropsychiatric symptoms in 112 children aged 3-5 years whose mothers had participated in a longitudinal study of obesity in pregnancy (50 very severe obesity, BMI ⩾40 kg/m2, obese class III and 62 lean, BMI 18.5-25 kg/m2). The mothers completed the Conners' Hyperactivity Scale, Early Symptomatic Syndrome Eliciting Neurodevelopmental Clinical Examination Questionnaire (ESSENCE-Q), Child's Sleep Habits Questionnaire (CSHQ), Strengths and Difficulties Questionnaire (SDQ), and Child Behavior Checklist (CBCL) to assess child neuropsychiatric symptoms. Covariates included child's sex, age, birthweight, gestational age, socioeconomic deprivation levels, maternal age, parity, smoking status during pregnancy, gestational diabetes and maternal concurrent symptoms of anxiety and depression assessed using State Anxiety of Spielberger State-Trait Anxiety Index (STAI) and General Health Questionnaire (GHQ), respectively. RESULTS: Children exposed to prenatal maternal very severe obesity had significantly higher scores in the Conners' Hyperactivity Scale; ESSENCE-Q; total sleep problems in CSHQ; hyperactivity, conduct problems and total difficulties scales of the SDQ; higher externalizing and total problems, anxious/depressed, aggressive behaviour and other problem syndrome scores and higher DSM-oriented affective, anxiety and ADHD problems in CBCL. Prenatal maternal very severe obesity remained a significant predictor of child neuropsychiatric problems across multiple scales independent of demographic factors, prenatal factors and maternal concurrent symptoms of anxiety and depression. CONCLUSIONS: Prenatal maternal very severe obesity is a strong predictor of increased neuropsychiatric problems in early childhood.
[Mh] Termos MeSH primário: Transtornos de Deficit da Atenção e do Comportamento Disruptivo/epidemiologia
Transtornos do Comportamento Infantil/epidemiologia
Obesidade/epidemiologia
Efeitos Tardios da Exposição Pré-Natal/epidemiologia
[Mh] Termos MeSH secundário: Adulto
Assistência ao Convalescente
Transtornos de Deficit da Atenção e do Comportamento Disruptivo/etiologia
Transtornos do Comportamento Infantil/etiologia
Pré-Escolar
Feminino
Seres Humanos
Obesidade/complicações
Gravidez
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171128
[Lr] Data última revisão:
171128
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:161026
[St] Status:MEDLINE
[do] DOI:10.1017/S0033291716002452


  5 / 2511 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29016602
[Au] Autor:Chen YC; Hwang-Gu SL; Ni HC; Liang SH; Lin HY; Lin CF; Tseng YH; Gau SS
[Ad] Endereço:Division of Clinical Psychology, Graduate Institute of Behavioral Sciences, College of Medicine, Chang Gung University, Tao-Yuan, Taiwan.
[Ti] Título:Relationship between parenting stress and informant discrepancies on symptoms of ADHD/ODD and internalizing behaviors in preschool children.
[So] Source:PLoS One;12(10):e0183467, 2017.
[Is] ISSN:1932-6203
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Parent and teacher ratings of child behaviors are often discrepant, and these discrepancies may be correlated with parenting stress. The present study explored whether various parenting stress factors are associated with discrepancies between parent and teacher ratings of attention-deficit/hyperactivity disorder and oppositional defiant disorder (ODD) as well as internalizing symptoms in preschool children. We recruited 299 Taiwanese preschool children (aged 4-6 years) from the community or via clinical referrals. A structural equation modeling was used to analyze the relationships among three factors derived from the Parenting Stress Index-Short Form and informant discrepancies on symptoms of inattention, hyperactivity/impulsivity, ODD, and internalizing behaviors. Scores reported by parents were higher for each of the symptoms examined than those reported by teachers, and the degree of agreement between informants ranged from low to moderate. The parental distress factor of parenting stress was associated only with parent ratings, whereas other factors of parenting stress-parent-child dysfunctional interaction and parents' stress resulted from their child's temperament-were correlated with both parent and teacher ratings. Only parental distress factor predicted informant discrepancies for all behavioral symptoms assessed. Our findings suggest that parental distress should be considered when parent rating scores show significant discrepancies from that of teacher rating scores.
[Mh] Termos MeSH primário: Transtorno do Deficit de Atenção com Hiperatividade/psicologia
Transtornos de Deficit da Atenção e do Comportamento Disruptivo/psicologia
Pais/psicologia
Estresse Psicológico/psicologia
[Mh] Termos MeSH secundário: Transtorno do Deficit de Atenção com Hiperatividade/epidemiologia
Transtornos de Deficit da Atenção e do Comportamento Disruptivo/epidemiologia
Criança
Pré-Escolar
Feminino
Seres Humanos
Masculino
Poder Familiar/psicologia
Professores Escolares/psicologia
Taiwan/epidemiologia
Temperamento
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171031
[Lr] Data última revisão:
171031
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171011
[St] Status:MEDLINE
[do] DOI:10.1371/journal.pone.0183467


  6 / 2511 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
Texto completo
[PMID]:28791693
[Au] Autor:Loy JH; Merry SN; Hetrick SE; Stasiak K
[Ad] Endereço:Child and Adolescent Mental Health, Waikato DHB, 206 Colllingwood Street, Hamilton, New Zealand.
[Ti] Título:Atypical antipsychotics for disruptive behaviour disorders in children and youths.
[So] Source:Cochrane Database Syst Rev;8:CD008559, 2017 08 09.
[Is] ISSN:1469-493X
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: This is an update of the original Cochrane Review, last published in 2012 (Loy 2012). Children and youths with disruptive behaviour disorders may present to health services, where they may be treated with atypical antipsychotics. There is increasing usage of atypical antipsychotics in the treatment of disruptive behaviour disorders. OBJECTIVES: To evaluate the effect and safety of atypical antipsychotics, compared to placebo, for treating disruptive behaviour disorders in children and youths. The aim was to evaluate each drug separately rather than the class effect, on the grounds that each atypical antipsychotic has different pharmacologic binding profile (Stahl 2013) and that this is clinically more useful. SEARCH METHODS: In January 2017, we searched CENTRAL, MEDLINE, Embase, five other databases and two trials registers. SELECTION CRITERIA: Randomised controlled trials of atypical antipsychotics versus placebo in children and youths aged up to and including 18 years, with a diagnosis of disruptive behaviour disorders, including comorbid ADHD. The primary outcomes were aggression, conduct problems and adverse events (i.e. weight gain/changes and metabolic parameters). The secondary outcomes were general functioning, noncompliance, other adverse events, social functioning, family functioning, parent satisfaction and school functioning. DATA COLLECTION AND ANALYSIS: We used standard methodological procedures expected by Cochrane. Two review authors (JL and KS) independently collected, evaluated and extracted data. We used the GRADE approach to assess the quality of the evidence. We performed meta-analyses for each of our primary outcomes, except for metabolic parameters, due to inadequate outcome data. MAIN RESULTS: We included 10 trials (spanning 2000 to 2014), involving a total of 896 children and youths aged five to 18 years. Bar two trials, all came from an outpatient setting. Eight trials assessed risperidone, one assessed quetiapine and one assessed ziprasidone. Nine trials assessed acute efficacy (over four to 10 weeks); one of which combined treatment with stimulant medication and parent training. One trial was a six-month maintenance trial assessing symptom recurrence.The quality of the evidence ranged from low to moderate. Nine studies had some degree of pharmaceutical support/funding. Primary outcomesUsing the mean difference (MD), we combined data from three studies (238 participants) in a meta-analysis of aggression, as assessed using the Aberrant Behaviour Checklist (ABC) ‒ Irritability subscale. We found that youths treated with risperidone show reduced aggression compared to youths treated with placebo (MD -6.49, 95% confidence interval (CI) -8.79 to -4.19; low-quality evidence). Using the standardised mean difference (SMD), we pooled data from two risperidone trials (190 participants), which used different scales: the Overt Aggression Scale ‒ Modified (OAS-M) Scale and the Antisocial Behaviour Scale (ABS); as the ABS had two subscales that could not be combined (reactive and proactive aggression), we performed two separate analyses. When we combined the ABS Reactive subscale and the OAS-M, the SMD was -1.30 in favour of risperidone (95% CI -2.21 to -0.40, moderate-quality evidence). When we combined the ABS Proactive subscale and OAS-M, the SMD was -1.12 (95% CI -2.30 to 0.06, moderate-quality evidence), suggesting uncertainty about the estimate of effect, as the confidence intervals overlapped the null value. In summary, there was some evidence that aggression could be reduced by risperidone. Data were lacking on other atypical antipsychotics, like quetiapine and ziprasidone, with regard to their effects on aggression.We pooled data from two risperidone trials (225 participants) in a meta-analysis of conduct problems, as assessed using the Nisonger Child Behaviour Rating Form ‒ Conduct Problem subscale (NCBRF-CP). This yielded a final mean score that was 8.61 points lower in the risperidone group compared to the placebo group (95% CI -11.49 to -5.74; moderate-quality evidence).We investigated the effect on weight by performing two meta-analyses. We wanted to distinguish between the effects of antipsychotic medication only and the combined effect with stimulants, since the latter can have a counteracting effect on weight gain due to appetite suppression. Pooling two trials with risperidone only (138 participants), we found that participants on risperidone gained 2.37 kilograms (kg) more (95% CI 0.26 to 4.49; moderate-quality evidence) than those on placebo. When we added a trial where all participants received a combination of risperidone and stimulants, we found that those on the combined treatment gained 2.14 kg more (95% CI 1.04 to 3.23; 3 studies; 305 participants; low-quality evidence) than those on placebo. Secondary outcomesOut of the 10 included trials, three examined general functioning, social functioning and parent satisfaction. No trials examined family or school functioning. Data on non-compliance/attrition rate and other adverse events were available from all 10 trials. AUTHORS' CONCLUSIONS: There is some evidence that in the short term risperidone may reduce aggression and conduct problems in children and youths with disruptive behaviour disorders There is also evidence that this intervention is associated with significant weight gain.For aggression, the difference in scores of 6.49 points on the ABC ‒ Irritability subscale (range 0 to 45) may be clinically significant. It is challenging to interpret the clinical significance of the differential findings on two different ABS subscales as it may be difficult to distinguish between reactive and proactive aggression in clinical practice. For conduct problems, the difference in scores of 8.61 points on the NCBRF-CP (range 0 to 48) is likely to be clinically significant. Weight gain remains a concern.Caution is required in interpreting the results due to the limitations of current evidence and the small number of high-quality trials. There is a lack of evidence to support the use of quetiapine, ziprasidone or any other atypical antipsychotic for disruptive behaviour disorders in children and youths and no evidence for children under five years of age. It is uncertain to what degree the efficacy found in clinical trials will translate into real-life clinical practice. Given the effectiveness of parent-training interventions in the management of these disorders, and the somewhat equivocal evidence on the efficacy of medication, it is important not to use medication alone. This is consistent with current clinical guidelines.
[Mh] Termos MeSH primário: Agressão/efeitos dos fármacos
Antipsicóticos/uso terapêutico
Transtornos de Deficit da Atenção e do Comportamento Disruptivo/tratamento farmacológico
Dibenzotiazepinas/uso terapêutico
Piperazinas/uso terapêutico
Fumarato de Quetiapina/uso terapêutico
Risperidona/uso terapêutico
Tiazóis/uso terapêutico
[Mh] Termos MeSH secundário: Adolescente
Antipsicóticos/efeitos adversos
Transtornos de Ansiedade/tratamento farmacológico
Transtorno do Deficit de Atenção com Hiperatividade/tratamento farmacológico
Criança
Pré-Escolar
Transtorno da Conduta/tratamento farmacológico
Transtorno Depressivo Maior/tratamento farmacológico
Dibenzotiazepinas/efeitos adversos
Seres Humanos
Ensaios Clínicos Controlados Aleatórios como Assunto
Risperidona/efeitos adversos
Ganho de Peso
[Pt] Tipo de publicação:JOURNAL ARTICLE; META-ANALYSIS; RESEARCH SUPPORT, NON-U.S. GOV'T; REVIEW
[Nm] Nome de substância:
0 (Antipsychotic Agents); 0 (Dibenzothiazepines); 0 (Piperazines); 0 (Thiazoles); 2S3PL1B6UJ (Quetiapine Fumarate); 6UKA5VEJ6X (ziprasidone); L6UH7ZF8HC (Risperidone)
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170919
[Lr] Data última revisão:
170919
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170810
[St] Status:MEDLINE
[do] DOI:10.1002/14651858.CD008559.pub3


  7 / 2511 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28347949
[Au] Autor:Munhoz TN; Santos IS; Barros AJD; Anselmi L; Barros FC; Matijasevich A
[Ad] Endereço:Postgraduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil; Faculty of Psychology, Federal University of Pelotas, Pelotas, Brazil. Electronic address: tyagomunhoz@hotmail.com.
[Ti] Título:Perinatal and postnatal risk factors for disruptive mood dysregulation disorder at age 11: 2004 Pelotas Birth Cohort Study.
[So] Source:J Affect Disord;215:263-268, 2017 Jun.
[Is] ISSN:1573-2517
[Cp] País de publicação:Netherlands
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: To date, there have been few studies of DMDD examining the risk factors during gestation and during the first years of life. We assessed the perinatal and postnatal risk factors associated with the occurrence of disruptive mood dysregulation disorder (DMDD) by 11 years of age. METHODS: Prospective longitudinal study. Mothers completed a standardized questionnaire shortly after childbirth. We used the Development and Well-Being Assessment, administered to the mothers or legal guardians, to identify DMDD among the 11-year-old subjects. We also employed logistic regression to perform bivariate and multivariate analyses, using a theoretical model of conceptual analysis. RESULTS: We evaluated data related to 3563 subjects at 11 years of age. The prevalence of DMDD was 2.5% (95% CI=2.0-3.0). After adjusting for potential confounders, we found that the early risk factors for the development of DMDD by 11 years of age were maternal mood symptoms during pregnancy, maternal depression during the first years after childbirth, and low maternal level of education. LIMITATIONS: We were unable to evaluate the genetic characteristics of the family at the birth of each subject, and there were no data available regarding the prenatal or postnatal mental health of the fathers. CONCLUSIONS: The prevalence of DMDD in early adolescence is low and its risk factors are related to potentially modifiable maternal characteristics. Scientific evidence indicates that DMDD is a major predictor of other psychiatric disorders, especially depression and anxiety. Effective prenatal and postnatal mental health care could prevent mental disorders in offspring.
[Mh] Termos MeSH primário: Transtornos de Deficit da Atenção e do Comportamento Disruptivo/epidemiologia
[Mh] Termos MeSH secundário: Adolescente
Adulto
Brasil/epidemiologia
Criança
Estudos de Coortes
Depressão/psicologia
Feminino
Seres Humanos
Estudos Longitudinais
Masculino
Transtornos do Humor/epidemiologia
Mães
Parto/psicologia
Gravidez
Complicações na Gravidez/psicologia
Prevalência
Estudos Prospectivos
Fatores de Risco
Inquéritos e Questionários
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1706
[Cu] Atualização por classe:170613
[Lr] Data última revisão:
170613
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170329
[St] Status:MEDLINE


  8 / 2511 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28266338
[Au] Autor:Berastegui C; Monfort E; Boudin B
[Ad] Endereço:Établissement d'hébergement pour personnes âgées dépendantes La Matinière, Saint-Jean-en-Royans, France.
[Ti] Título:Vocally disruptive behaviors management in older people with dementia.
[Ti] Título:Gestion des comportements d'agitation verbale chez les personnes âgées souffrant de pathologie démentielle..
[So] Source:Geriatr Psychol Neuropsychiatr Vieil;15(1):35-46, 2017 Mar 01.
[Is] ISSN:2115-7863
[Cp] País de publicação:France
[La] Idioma:eng
[Ab] Resumo:Although shouting is a common psycho-behavioral symptom in geriatric institutions, the question of its assessment and treatment remains seldom studied and has rarely been the subject of specific recommendations. The combination of the focus group method and brainstorming has emerged as a methodology both relevant and feasible in geriatric facility to identify the coping strategies used by professionals and generalize guidelines for clinical observation and vocally disruptive behaviors management (shouting). The standardized gathering of professional experiences in nursing homes and their analysis with reference to results of the literature enabled the development of an analytical and clinical decision making diagram that can be an operational tool to cope with the occurrence of shouting in older people with dementia. Five types of triggers/aggravating shoutings emerged: 1) physical or moral pain and emotional reactions, 2) presence of sensory loss, 3) social isolation, under-stimulation or hyper sensitivity to stimulation and care, 4) reminiscences and 5) re-emergence of painful memories and loss of language skills. These factors have been associated with five methods of intervention : 1) pharmacological treatments, 2) animations, such as listening to music, physical activity and workshops using therapeutic mediation, 3) family or animal support and use of interventions to provide relaxation or stimulation, 4) interventions to deal with sensory deficits and 5) interventions modifying the environment.
[Mh] Termos MeSH primário: Transtornos de Deficit da Atenção e do Comportamento Disruptivo/psicologia
Transtornos de Deficit da Atenção e do Comportamento Disruptivo/terapia
Demência/psicologia
[Mh] Termos MeSH secundário: Idoso
Idoso de 80 Anos ou mais
Transtornos de Deficit da Atenção e do Comportamento Disruptivo/etiologia
Demência/complicações
Feminino
Seres Humanos
Masculino
Casas de Saúde
Comportamento Verbal
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171004
[Lr] Data última revisão:
171004
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170308
[St] Status:MEDLINE
[do] DOI:10.1684/pnv.2017.0657


  9 / 2511 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28262156
[Au] Autor:Gomez R
[Ad] Endereço:Federation University Australia, Australia. Electronic address: rapson.gomez@federation.edu.au.
[Ti] Título:Factor structure of parent and teacher ratings of the ODD symptoms for Malaysian primary school children.
[So] Source:Asian J Psychiatr;25:22-26, 2017 Feb.
[Is] ISSN:1876-2026
[Cp] País de publicação:Netherlands
[La] Idioma:eng
[Ab] Resumo:This present study used confirmatory factor analysis (CFA) to examine the applicability of one-, two- three- and second order Oppositional Defiant Disorder (ODD) factor models, proposed in previous studies, in a group of Malaysian primary school children. These models were primarily based on parent reports. In the current study, parent and teacher ratings of the ODD symptoms were obtained for 934 children. For both groups of respondents, the findings showing some support for all models examined, with most support for a second order model with Burke et al. (2010) three factors (oppositional, antagonistic, and negative affect) as the primary factors. The diagnostic implications of the findings are discussed.
[Mh] Termos MeSH primário: Transtornos de Deficit da Atenção e do Comportamento Disruptivo/classificação
Modelos Estatísticos
[Mh] Termos MeSH secundário: Criança
Análise Fatorial
Feminino
Seres Humanos
Malásia
Masculino
Pais
Professores Escolares
Instituições Acadêmicas
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1703
[Cu] Atualização por classe:170313
[Lr] Data última revisão:
170313
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170307
[St] Status:MEDLINE


  10 / 2511 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28210827
[Au] Autor:Lake JK; Denton D; Lunsky Y; Shui AM; Veenstra-VanderWeele J; Anagnostou E
[Ad] Endereço:Underserved Populations Program Centre for Addiction and Mental Health, 1001 Queen St. W., Toronto, ON, M6J 1H4, Canada. johanna.lake@camh.ca.
[Ti] Título:Medical Conditions and Demographic, Service and Clinical Factors Associated with Atypical Antipsychotic Medication Use Among Children with An Autism Spectrum Disorder.
[So] Source:J Autism Dev Disord;47(5):1391-1402, 2017 May.
[Is] ISSN:1573-3432
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:This study aimed to describe rates of antipsychotic medication use and the association between their use and demographics, clinical variables, and the use of behavioral/education services among children with ASD. For children with ASD ages 2-11 (n = 4749) and those 12-17 (n = 401), 5.4 and 17.7% were prescribed at least one atypical antipsychotic medication respectively. In the multivariable model of young children, older age, use of multiple psychotropic medications, prior ASD diagnosis, non-white Hispanic race/ethnicity, and oppositional defiant problems were associated with antipsychotic use. Among older children, only older age was associated with antipsychotic use. In at least one age group, antipsychotic medication use was also related to behaviour, family and occupational therapy, public insurance, site region, externalizing problems, body mass index, and sleep and gastrointestinal problems.
[Mh] Termos MeSH primário: Antipsicóticos/uso terapêutico
Transtorno do Espectro Autista/tratamento farmacológico
Psicoterapia/estatística & dados numéricos
Psicotrópicos/uso terapêutico
[Mh] Termos MeSH secundário: Adolescente
Fatores Etários
Transtornos de Deficit da Atenção e do Comportamento Disruptivo/psicologia
Transtornos de Deficit da Atenção e do Comportamento Disruptivo/terapia
Transtorno do Espectro Autista/psicologia
Criança
Pré-Escolar
Grupos de Populações Continentais/estatística & dados numéricos
Grupos Étnicos/estatística & dados numéricos
Feminino
Seres Humanos
Masculino
Psicoterapia/métodos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Antipsychotic Agents); 0 (Psychotropic Drugs)
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171101
[Lr] Data última revisão:
171101
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170218
[St] Status:MEDLINE
[do] DOI:10.1007/s10803-017-3058-8



página 1 de 252 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde